Patient Safety

Patient Safety News

  • New Single-pill Combo Effective Against HIV-1 A new fixed-dose combination of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is noninferior to fixed-dose efavirenz/emtricitabine/TDF (EFV/FTC/TDF) in treatment-naive adults with HIV-1 infection, according to results from the DRIVE-AHEAD trial.
  • ERS 2018 Long-term Benralizumab Safe and Effective for Severe Asthma The drug is safe for severe uncontrolled asthma over 2 years, and reduces exacerbations in vast majority of patients, according to results from the 1-year BORA extension study.

Patient Safety Perspective